Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?

BioEssays

Volumn 36, Issue 7, 2014, Pages 672-686

  Ramot, Yuval ^a   Paus, Ralf ^b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

HPA; HPT; Prolactin; Skin; TRH; TSH

Indexed keywords

BETA ENDORPHIN; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKERATIN 15; CYTOKERATIN 17; ENDOCANNABINOID; HORMONE; HYDROCORTISONE; KERATIN; NEUROHORMONE; OPIATE; PARATHYROID HORMONE RELATED PROTEIN; PROLACTIN; PROLACTIN RECEPTOR; PROTIRELIN; THYROTROPIN; THYROXINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DISCOID LUPUS ERYTHEMATOSUS; DOWN REGULATION; EPITHELIAL PROGENITOR CELL; EPITHELIZATION; GENE EXPRESSION REGULATION; GENE MUTATION; HAIR; HAIR COLOR; HAIR FOLLICLE; HAIR GROWTH; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; INTERMEDIATE FILAMENT; KERATINOCYTE; LICHEN PLANUS; NEUROENDOCRINE SYSTEM; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; PSORIASIS; SKIN DISEASE; SKIN EPITHELIUM; SKIN PIGMENTATION; STEM CELL; UPREGULATION; WOUND HEALING; ANIMAL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; METABOLISM; NEUROSECRETION; PHYSIOLOGY; SKIN DISEASES;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; KERATINS; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA; WOUND HEALING;

EID: 84901853688     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201400006     Document Type: Article

References (120)

1. Paus R. 2011. A neuroendocrinological perspective on human hair follicle pigmentation. Pigment Cell Melanoma Res 24: 89-106.
2. Paus R, Theoharides TC, Arck PC. 2006. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 27: 32-9.
3. Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, et al. 2012. Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol 212: 1-115.
4. Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, et al. 2008. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 19: 17-24.
5. Foitzik K, Langan EA, Paus R. 2009. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 129: 1071-87.
6. Langan EA, Ramot Y, Hanning A, Poeggeler B, et al. 2010. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol 162: 1127-31.
7. Ramot Y, Biro T, Tiede S, Toth BI, et al. 2010. Prolactin - a novel neuroendocrine regulator of human keratin expression in situ. FASEB J 24: 1768-79.
8. Foitzik K, Krause K, Conrad F, Nakamura M, et al. 2006. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168: 748-56.
9. Foitzik K, Krause K, Nixon AJ, Ford CA, et al. 2003. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol 162: 1611-21.
10. Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, et al. 2010. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21: 569-77.
11. Gaspar E, Hardenbicker C, Bodo E, Wenzel B, et al. 2010. Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J 24: 393-403.
12. Gaspar E, Nguyen-Thi KT, Hardenbicker C, Tiede S, et al. 2011. Thyrotropin-releasing hormone selectively stimulates human hair follicle pigmentation. J Invest Dermatol 131: 2368-77.
13. Meier NT, Haslam IS, Pattwell DM, Zhang GY, et al. 2013. Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skin. PLoS One 8: e73596.
14. Ramot Y, Zhang G, Biro T, Langbein L, et al. 2013. Is thyrotropin-releasing hormone (TRH) a novel neuroendocrine modulator of keratin expression in human skin? Br J Dermatol 169: 146-51
15. Vidali S, Knuever J, Lerchner J, Giesen M, et al. 2014. Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol 134: 33-42.
16. Knuever J, Poeggeler B, Gaspar E, Klinger M, et al. 2012. Thyrotropin-releasing hormone controls mitochondrial biology in human epidermis. J Clin Endocrinol Metab 97: 978-86.
17. Bodo E, Kany B, Gaspar E, Knuver J, et al. 2010. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology 151: 1633-42.
18. Ramot Y, Zhang G, Biro T, Lisztes E, et al. 2011. TSH is a novel neuroendocrine regulator of selected keratins in the human hair follicle. J Dermatol Sci 64: 67-70.
19. Bodo E, Kromminga A, Biro T, Borbiro I, et al. 2009. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol 129: 1126-39.
20. Poeggeler B, Knuever J, Gaspar E, Biro T, et al. 2010. Thyrotropin powers human mitochondria. FASEB J 24: 1525-31.
21. Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, et al. 2013. Key role of CRF in the skin stress response system. Endocr Rev 34: 827-84.
22. Ito N, Ito T, Kromminga A, Bettermann A, et al. 2005. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 19: 1332-4.
23. Slominski A, Wortsman J, Kohn L, Ain KB, et al. 2002. Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol 119: 1449-55.
24. Slominski A, Wortsman J, Tuckey RC, Paus R. 2007. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol 265-266: 143-9.
25. van Beek N, Bodo E, Kromminga A, Gaspar E, et al. 2008. Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab 93: 4381-8.
26. Paus R, Arck P. 2009. Neuroendocrine perspectives in alopecia areata: does stress play a role? J Invest Dermatol 129: 1324-6.
27. Telek A, Biro T, Bodo E, Toth BI, et al. 2007. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J 21: 3534-41.
28. Harvima IT, Nilsson G. 2012. Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis. Expert Rev Clin Immunol 8: 235-41.
29. Moll R, Divo M, Langbein L. 2008. The human keratins: biology and pathology. Histochem Cell Biol 129: 705-33.
30. Kim JS, Lee CH, Su BY, Coulombe PA. 2012. Mathematical modeling of the impact of actin and keratin filaments on keratinocyte cell spreading. Biophys J 103: 1828-38.
31. Rotty JD, Coulombe PA. 2012. A wound-induced keratin inhibits Src activity during keratinocyte migration and tissue repair. J Cell Biol 197: 381-9.
32. Wong P, Coulombe PA. 2003. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol 163: 327-37.
33. Lessard JC, Pina-Paz S, Rotty JD, Hickerson RP, et al. 2013. Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci USA 110: 19537-42.
34. Tong X, Coulombe PA. 2006. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev 20: 1353-64.
35. Pan X, Hobbs RP, Coulombe PA. 2013. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Curr Opin Cell Biol 25: 47-56.
36. Ramot Y, Paus R, Tiede S, Zlotogorski A. 2009. Endocrine controls of keratin expression. BioEssays 31: 389-99.
37. Safer JD, Crawford TM, Holick MF. 2004. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology 145: 2357-61.
38. Radoja N, Stojadinovic O, Waseem A, Tomic-Canic M, et al. 2004. Thyroid hormones and gamma interferon specifically increase K15 keratin gene transcription. Mol Cell Biol 24: 3168-79.
39. Horn S, Heuer H. 2010. Thyroid hormone action during brain development: more questions than answers. Mol Cell Endocrinol 315: 19-26.
40. Billoni N, Buan B, Gautier B, Gaillard O, et al. 2000. Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 142: 645-52.
41. Paus R. 2010. Exploring the "thyroid-skin connection": concepts, questions, and clinical relevance. J Invest Dermatol 130: 7-10.
42. Schneider MR, Schmidt-Ullrich R, Paus R. 2009. The hair follicle as a dynamic miniorgan. Curr Biol 19: R132-42.
43. Langbein L, Schweizer J. 2005. Keratins of the human hair follicle. Int Rev Cytol 243: 1-78.
44. Cianfarani F, Baldini E, Cavalli A, Marchioni E, et al. 2010. TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol 130: 93-101.
45. Bigliardi PL, Bigliardi-Qi M, Buechner S, Rufli T. 1998. Expression of mu-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 111: 297-301.
46. Bigliardi-Qi M, Bigliardi PL, Buchner S, Rufli T. 1999. Characterization of mu-opiate receptor in human epidermis and keratinocytes. Ann N Y Acad Sci 885: 368-71.
47. Nissen JB, Kragballe K. 1997. Enkephalins modulate differentiation of normal human keratinocytes in vitro. Exp Dermatol 6: 222-9.
48. Zagon IS, Wu Y, McLaughlin PJ. 1996. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. J Invest Dermatol 106: 490-7.
49. Tominaga M, Ogawa H, Takamori K. 2007. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J Invest Dermatol 127: 2228-35.
50. Twillman RK, Long TD, Cathers TA, Mueller DW. 1999. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 17: 288-92.
51. Bigliardi PL, Sumanovski LT, Buchner S, Rufli T, et al. 2003. Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression. J Invest Dermatol 120: 145-52.
52. Bigliardi-Qi M, Bigliardi PL, Eberle AN, Buchner S, et al. 2000. Beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Invest Dermatol 114: 527-32.
53. Kohl A, Werner A, Buntrock P, Diezel W, et al. 1989. The effect of the peptide dalargin on wound healing. Dermatol Monatsschr 175: 561-72.
54. Ormandy CJ, Naylor M, Harris J, Robertson F, et al. 2003. Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res 58: 297-323.
55. Hens JR, Dann P, Zhang JP, Harris S, et al. 2007. BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction. Development 134: 1221-30.
56. Eastwood J, Offutt C, Menon K, Keel M, et al. 2007. Identification of markers for nipple epidermis: changes in expression during pregnancy and lactation. Differentiation 75: 75-83.
57. Toth BI, Dobrosi N, Dajnoki A, Czifra G, et al. 2011. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 131: 1095-104.
58. Ramot Y, Sugawara K, Zakany N, Toth B, et al. 2013. A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ. PeerJ 1: e40.
59. Langan EA, Ramot Y, Goffin V, Griffiths CE, et al. 2010. Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol 130: 886-91.
60. Ferraris J, Boutillon F, Bernadet M, Seilicovich A, et al. 2012. Prolactin receptor antagonism in mouse anterior pituitary: effects on cell turnover and prolactin receptor expression. Am J Physiol Endocrinol Metab 302: E356-64.
61. Langan EA, Griffiths CE, Paus R. 2012. Utilizing the hair follicle to dissect the regulation and autocrine/paracrine activities of prolactin in humans. Am J Physiol Endocrinol Metab 302: E1311-2.
62. Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, et al. 2002. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol 16: 2675-91.
63. Sugawara K, Biro T, Tsuruta D, Toth BI, et al. 2012. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 129: 726-38.e8.
64. Saito A, Ballinger MD, Pletnikov MV, Wong DF, et al. 2013. Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis 53: 10-7.
65. Trakhtenberg EF, Goldberg JL. 2012. The role of serotonin in axon and dendrite growth. Int Rev Neurobiol 106: 105-26.
66. Romano D, Pertuit M, Rasolonjanahary R, Barnier JV, et al. 2006. Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells. Endocrinology 147: 6036-45.
67. Fortier AM, Van Themsche C, Asselin E, Cadrin M. 2010. Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells. FEBS Lett 584: 984-8.
68. Goldhar AS, Duan R, Ginsburg E, Vonderhaar BK. 2011. Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP. Mol Cell Endocrinol 335: 148-57.
69. Balasubramanian S, Eckert RL. 2007. Keratinocyte proliferation, differentiation, and apoptosis - differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol 224: 214-9.
70. McLean WH, Moore CB. 2011. Keratin disorders: from gene to therapy. Hum Mol Genet 20: R189-97.
71. Gu LH, Coulombe PA. 2007. Keratin function in skin epithelia: a broadening palette with surprising shades. Curr Opin Cell Biol 19: 13-23.
72. Kim HJ, Song SB, Yang Y, Eun YS, et al. 2011. Erythroid differentiation regulator 1 (Erdr1) is a proapototic factor in human keratinocytes. Exp Dermatol 20: 920-5.
73. Kim S, Wong P, Coulombe PA. 2006. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 441: 362-5.
74. Kim S, Coulombe PA. 2010. Emerging role for the cytoskeleton as an organizer and regulator of translation. Nat Rev Mol Cell Biol 11: 75-81.
75. Zaballos MA, Santisteban P. 2013. FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis. Mol Endocrinol 27: 50-62.
76. Khomane KS, Meena CL, Jain R, Bansal AK. 2011. Novel thyrotropin-releasing hormone analogs: a patent review. Expert Opin Ther Pat 21: 1673-91.
77. Galofre JC, Chacon AM, Latif R. 2013. Targeting thyroid diseases with TSH receptor analogs. Endocrinol Nutr 60: 590-8.
78. Bernichtein S, Touraine P, Goffin V. 2010. New concepts in prolactin biology. J Endocrinol 206: 1-11.
79. Stein C, Kuchler S. 2013. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 34: 303-12.
80. Ichikawa E, Watanabe S, Takahashi H. 1997. Keratin and involucrin expression in discoid lupus erythematosus and lichen planus. Arch Dermatol Res 289: 519-26.
81. Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, Good MF, et al. 1999. Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol 117: 580-6.
82. Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. 2010. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 42: 910-4.
83. Fu M, Wang G. 2012. Keratin 17 as a therapeutic target for the treatment of psoriasis. J Dermatol Sci 67: 161-5.
84. Chamcheu JC, Siddiqui IA, Syed DN, Adhami VM, et al. 2011. Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys 508: 123-37.
85. Atkinson SD, McGilligan VE, Liao H, Szeverenyi I, et al. 2011. Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J Invest Dermatol 131: 2079-86.
86. Hickerson RP, Smith FJ, Reeves RE, Contag CH, et al. 2008. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Invest Dermatol 128: 594-605.
87. Shimomura Y. 2012. Congenital hair loss disorders: rare, but not too rare. J Dermatol 39: 3-10.
88. Rogers MA, Langbein L, Praetzel-Wunder S, Winter H, et al. 2006. Human hair keratin-associated proteins (KAPs). Int Rev Cytol 251: 209-63.
89. Giesen M, Gruedl S, Holtkoetter O, Fuhrmann G, et al. 2011. Ageing processes influence keratin and KAP expression in human hair follicles. Exp Dermatol 20: 759-61.
90. Trueeb RM, Tobin DJ. 2010. Aging Hair. Heidelberg: Spinger.
91. Purba TS, Haslam IS, Poblet E, Jimenez F, et al. 2014. Human epithelial hair follicle stem cells and their progeny: current state of knowledge, the widening gap in translational research and future challenges. BioEssays 36: 513-25.
92. Harries MJ, Paus R. 2010. The pathogenesis of primary cicatricial alopecias. Am J Pathol 177: 2152-62.
93. Paus R, Haslam IS, Sharov AA, Botchkarev VA. 2013. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14: e50-9.
94. Sun HY, Zhou GM, Wang Q, Lin XC, et al. 2014. In vitro culture system for keratinocytes obtained from oral lichen planus lesions. Clin Oral Investig 18: 1195-203.
95. MacNeil S, Shepherd J, Smith L. 2011. Production of tissue-engineered skin and oral mucosa for clinical and experimental use. Methods Mol Biol 695: 129-53.
96. Ramot Y, Tiede S, Biro T, Abu Bakar MH, et al. 2011. Spermidine promotes human hair growth and is a novel modulator of human epithelial stem cell functions. PLoS One 6: e22564.
97. Cecyre B, Zabouri N, Huppe-Gourgues F, Bouchard JF, et al. 2013. Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice. Invest Ophthalmol Vis Sci 54: 8079-90.
98. Bigliardi-Qi M, Gaveriaux-Ruff C, Zhou H, Hell C, et al. 2006. Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74: 174-85.
99. Nillni EA, Sevarino KA. 1999. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr Rev 20: 599-648.
100. Sun Y, Lu X, Gershengorn MC. 2003. Thyrotropin-releasing hormone receptors - similarities and differences. J Mol Endocrinol 30: 87-97.
101. Davies T, Marians R, Latif R. 2002. The TSH receptor reveals itself. J Clin Invest 110: 161-4.
102. Klein JR. 2003. Physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid. Autoimmunity 36: 417-21.
103. Grammatopoulos DK. 2012. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol 166: 85-97.
104. Biro T, Toth BI, Hasko G, Paus R, et al. 2009. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 30: 411-20.
105. Fonseca BM, Costa MA, Almada M, Correia-da-Silva G, et al. 2013. Endogenous cannabinoids revisited: a biochemistry perspective. Prostaglandins Other Lipid Mediat 102-103: 13-30.
106. Al-Hasani R, Bruchas MR. 2011. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115: 1363-81.
107. Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, Bigliardi-Qi M. 2009. Opioids and the skin - where do we stand? Exp Dermatol 18: 424-30.
108. Feng Y, He X, Yang Y, Chao D, et al. 2012. Current research on opioid receptor function. Curr Drug Targets 13: 230-46.
109. Moll I, Kuhn C, Moll R. 1995. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 104: 910-5.
110. Moll R, Lowe A, Laufer J, Franke WW. 1992. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140: 427-47.
111. Langbein L, Yoshida H, Praetzel-Wunder S, Parry DA, et al. 2010. The keratins of the human beard hair medulla: the riddle in the middle. J Invest Dermatol 130: 55-73.
112. Schweizer J, Langbein L, Rogers MA, Winter H. 2007. Hair follicle-specific keratins and their diseases. Exp Cell Res 313: 2010-20.
113. Zbytek B, Pikula M, Slominski RM, Mysliwski A, et al. 2005. Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol 152: 474-80.
114. Zbytek B, Slominski AT. 2005. Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol 203: 118-26.
115. Pain S, Altobelli C, Boher A, Cittadini L, et al. 2011. Surface rejuvenating effect of Achillea millefolium extract. Int J Cosmet Sci 33: 535-42.
116. Mammone T, Marenus K, Maes D, Lockshin RA. 1998. The induction of terminal differentiation markers by the cAMP pathway in human HaCaT keratinocytes. Skin Pharmacol Appl Skin Physiol 11: 152-60.
117. Ghoubay-Benallaoua D, Pecha F, Goldschmidt P, Fialaire-Legendre A, et al. 2012. Effects of isoproterenol and cholera toxin on human limbal epithelial cell cultures. Curr Eye Res 37: 644-53.
118. Paradisi A, Pasquariello N, Barcaroli D, Maccarrone M. 2008. Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283: 6005-12.
119. Gschwandtner M, Mildner M, Mlitz V, Gruber F, et al. 2013. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy 68: 37-47.
120. Kurzen H, Henrich C, Booken D, Poenitz N, et al. 2006. Functional characterization of the epidermal cholinergic system in vitro. J Invest Dermatol 126: 2458-72.